![Gary Jennings](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary Jennings
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Gary Jennings
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
JADO Technologies GmbH
![]() JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany.
8
| Extinct | Drugstore Chains | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gary Jennings via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Karlsruhe | College/University | Director/Board Member Doctorate Degree | |
Isarna Therapeutics GmbH
![]() Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Biotechnology | Founder | |
Henley Business School Ltd. | College/University | Masters Business Admin | |
BAYER AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCB Celltech
![]() UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
University of Cape Town | College/University | Undergraduate Degree | |
AudioCure Pharma GmbH
![]() AudioCure Pharma GmbH Pharmaceuticals: MajorHealth Technology AudioCure Pharma GmbH provides preclinical research and clinical development of novel pharmacotherapies to treat disorders of the inner ear. It engages in the clinical development of drug candidates in neurodegenerative disease indications. The firm's offer medicine for the treatment of acute and chronic hearing impairments via local, regenerative therapy of the damaged nerve cells in the inner ear. The company was founded by Hans Rommelspacher in 2010 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing | |
Hanover College | College/University | Corporate Officer/Principal | |
Dresden University of Technology | College/University | Corporate Officer/Principal | |
University of Trieste | College/University | Doctorate Degree | |
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
University of Helsinki | College/University | Doctorate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Duitsland | 8 |
Verenigde Staten | 7 |
België | 4 |
Zuid-Afrika | 3 |
Denemarken | 2 |
Sectoraal
Health Technology | 13 |
Consumer Services | 10 |
Commercial Services | 3 |
Operationeel
Corporate Officer/Principal | 11 |
Founder | 5 |
Chief Executive Officer | 4 |
Director/Board Member | 4 |
Doctorate Degree | 3 |
Sterkste connecties
- Beurs
- Insiders
- Gary Jennings
- Bedrijfsconnecties